---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-114021"
form_type: "8-K"
ticker: "CERO"
cik: "0001870404"
company_name: "CERO THERAPEUTICS HOLDINGS, INC."
filed_at: "2024-12-31T23:59:59+00:00"
generated_at: "2026-05-28T21:59:57.941845+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# CERO Therapeutics issues ~84M new common shares and 8.4M warrants in December capital actions

## Summary
- From Dec 6-26, ~2,600 Series A and 213 Series B preferred shares converted into ~68M common shares.
- Issued 8.4M warrants at $0.0561/share to institutional investors on Dec 23 as condition to warrant exercises.
- Equity line issued ~16M common shares for ~$700k cash proceeds Dec 6-30.
- Preferred warrants exercised: 962 warrants for $962k stated value, netting $769.6k cash.

## SEC filing metadata
- accession: 0001213900-24-114021
- form_type: 8-K
- ticker: CERO
- cik: 0001870404
- company_name: CERO THERAPEUTICS HOLDINGS, INC.
- filed_at: 2024-12-31T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1870404/000121390024114021/0001213900-24-114021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1870404/000121390024114021/ea0226496-8k_cerotherap.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-114021
- JSON: https://secwatch.observer/filing/0001213900-24-114021.json
- Plain text: https://secwatch.observer/filing/0001213900-24-114021.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.